Back to search results

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Abroad (travel likely)RecruitingPHASE3

Conditions

Eczema

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cahaba Dermatology & Skin Health Center, LLC, Birmingham, Alabama, United States

  • Arkansas Research Trials, North Little Rock, Arkansas, United States

  • Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego, California, United States

  • University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm, San Diego, California, United States

  • Solutions Through Advanced Research, Jacksonville, Florida, United States

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States

  • Saint Louis University - Department of Dermatology, St Louis, Missouri, United States

  • Medical University of South Carolina, Charleston, South Carolina, United States

  • Tribe Clinical Research, LLC, Greenville, South Carolina, United States

  • Texas Dermatology and Laser Specialists, San Antonio, Texas, United States

  • Beijing Children's hospital, Capital Medical University, Beijing, Beijing Municipality, China

  • Shenzhen Children's Hospital, Shenzhen, Guangdong, China

  • Hunan Children's Hospital, Changsha, Hunan, China

  • Dermatology Hospital of Jiangxi Province, Nanchang, Jiangxi, China

  • Shanghai Children's Hospital, Shanghai, Shanghai Municipality, China

  • Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China

  • Shanghai Children's Hospital, Shanghai, China

  • Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China

  • Universitätsklinikum Münster, Münster, North Rhine-Westphalia, Germany

  • Universitaetsklinikum Carl Gustav Carus, Technischen Universitaet Dresden, Dresden, Saxony, Germany

  • Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, Hungary

  • Trial Pharma Kft., Békéscsaba, Bekes County, Hungary

  • Clinexpert Kft., Budapest, Pest County, Hungary

  • University of Pecs, Pécs, Hungary

  • Queen's square Medical Facilities Queen's square Dermatology and Allergology, Yokohama, Kanagawa, Japan

  • Dermatology and Ophthalmology Kume Clinic, Sakai, Osaka, Japan

  • Sasamoto Children's Clinic, Setagaya-ku, Tokyo, Japan

  • Fukuoka National Hospital, Fukuoka, Japan

  • Saruta Dermatology Clinic, Fukuoka, Japan

  • Eukarya Pharmasite S.C., Monterrey, Nuevo León, Mexico

  • Arke SMO S.A. de C.V., Veracruz, Veracruz, Mexico

  • Servicios Hospitalarios de México S.A. de C.V. (Hospital Angeles Chihuahua), Chihuahua City, Mexico

  • LUXDERM Specjalistyczny Gabinet Dermatologiczny prof. dr hab. n. med. Dorota Krasowska, Lublin, Lublin Voivodeship, Poland

  • Centrum Medyczne Evimed, Warsaw, Masovian Voivodeship, Poland

  • DERMAPOLIS Medical Dermatology Center dr n. med. Edyta Gebska, Chorzów, Silesian Voivodeship, Poland

  • Centrum Medyczne Angelius Provita, Katowice, Silesian Voivodeship, Poland

  • Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak, Lodz, Łódź Voivodeship, Poland

  • Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, Poland

  • CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [LA Coruña], Spain

  • Hospital General de Granollers, Granollers, Barcelona [barcelona], Spain

  • Hospital Universitario Miguel Servet, Zaragoza, Spain

Study leads

  • Pfizer CT.gov Call Center

    Study Director

    Pfizer

View source on ClinicalTrials.gov(opens in a new tab)